DISPARATE STRUCTURAL EFFECTS ON LEFT-AND-RIGHT-VENTRICLES BY ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS AND CALCIUM-ANTAGONISTS IN ESSENTIAL-HYPERTENSION

被引:29
作者
ARISTIZABAL, D [1 ]
MESSERLI, FH [1 ]
FROHLICH, ED [1 ]
机构
[1] ALTON OCHSNER MED FDN & OCHSNER CLIN,NEW ORLEANS,LA 70121
关键词
D O I
10.1016/0002-9149(94)90679-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Reduced left ventricular (LV) mass and wall thick nesses with angiotensin-converting enzyme (ACE) inhibitors and calcium antagonists occur in essential hypertension. Experimental studies have shown that reduction in LV mass is related to hemodynamic as well as nonhemodynamic factors that may influence LV and also right ventricular (RV) structure. sixty-eight patients with essential hypertension were studied echocardiographically 4 to 8 weeks after antihypertensive therapy was initiated. LV dimensions and wall thicknesses, as well as RV free wall thickness, were measured using 2-dimensionally guided techniques. Patients were divided in 2 groups: those receiving either ACE inhibitors or calcium antagonists This short-term therapeutic period produced similar hemodynamic changes and reductions in LV mass in both groups. In these 2 groups of patients, we found opposite effects in RV free wall thickness. Thus, RV wall thickness increased from 0.44 +/- 0.02 to 0.56 +/- 0.02 cm (p <0.01) after therapy in the calcium antagonist group, whereas no change was found in the ACE inhibitor group (0.36 +/- 0.04 vs 0.34 +/- 0.04). These structural changes suggest that ACE inhibitors and calcium antagonists produce dissimilar effects on cardiac cell growth and growth reversal, which may be mediated through different nonhemodynamic effects after short-term therapy.
引用
收藏
页码:483 / 487
页数:5
相关论文
共 36 条
[1]   IMMEDIATE AND SHORT-TERM HEMODYNAMIC-EFFECTS OF DILTIAZEM IN PATIENTS WITH HYPERTENSION [J].
AMODEO, C ;
KOBRIN, I ;
VENTURA, HO ;
MESSERLI, FH ;
FROHLICH, ED .
CIRCULATION, 1986, 73 (01) :108-113
[2]  
Ando K, 1991, J VASC MED BIOL, V3, P117
[3]   CARDIOREPARATIVE EFFECTS OF LISINOPRIL IN RATS WITH GENETIC-HYPERTENSION AND LEFT-VENTRICULAR HYPERTROPHY [J].
BRILLA, CG ;
JANICKI, JS ;
WEBER, KT .
CIRCULATION, 1991, 83 (05) :1771-1779
[4]   REVERSAL OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS - A METAANALYSIS OF 109 TREATMENT STUDIES [J].
DAHLOF, B ;
PENNERT, K ;
HANSSON, L .
AMERICAN JOURNAL OF HYPERTENSION, 1992, 5 (02) :95-110
[5]   EFFECTS OF LEFT-VENTRICULAR HYPERTROPHY ON THE CORONARY CIRCULATION [J].
DELLSPERGER, KC ;
MARCUS, ML .
AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (22) :1504-1510
[6]   ECHOCARDIOGRAPHIC ASSESSMENT OF LEFT-VENTRICULAR HYPERTROPHY - COMPARISON TO NECROPSY FINDINGS [J].
DEVEREUX, RB ;
ALONSO, DR ;
LUTAS, EM ;
GOTTLIEB, GJ ;
CAMPO, E ;
SACHS, I ;
REICHEK, N .
AMERICAN JOURNAL OF CARDIOLOGY, 1986, 57 (06) :450-458
[7]   TIME COURSE OF REGRESSION OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS TREATED WITH ATENOLOL [J].
DUNN, FG ;
VENTURA, HO ;
MESSERLI, FH ;
KOBRIN, I ;
FROHLICH, ED .
CIRCULATION, 1987, 76 (02) :254-258
[8]   PATHOPHYSIOLOGIC ASSESSMENT OF HYPERTENSIVE HEART-DISEASE WITH ECHOCARDIOGRAPHY [J].
DUNN, FG ;
CHANDRARATNA, P ;
DECARVALHO, JGR ;
BASTA, LL ;
FROHLICH, ED .
AMERICAN JOURNAL OF CARDIOLOGY, 1977, 39 (06) :789-795
[9]  
FRENCH WJ, 1989, CARDIOVASC RES, V23, P699
[10]   IS ARTERIAL-PRESSURE THE SOLE FACTOR RESPONSIBLE FOR HYPERTENSIVE CARDIAC-HYPERTROPHY [J].
FROHLICH, ED ;
TARAZI, RC .
AMERICAN JOURNAL OF CARDIOLOGY, 1979, 44 (05) :959-963